In a mouse model of PDAC, the same vaccine induced protective immunity characterized by the expansion of effector and memory CD8+ T cells, CD4+ T cells (excluding Treg cells), and B cells, while reducing the amount of Treg cells in tumor-draining lymph nodes [68]. Here, CD8A is linked to neoplasm.